Scientific studies :
1 Bukhari SI, Manzoor M., Dhar MK “A comprehensive review of the pharmacological potential of Crocus sativus and its bioactive apocarotenoids”.Biomed Pharmacother[Online]. February 2018. Vol. 98, p. 733-745. Available at: < https://doi.org/10.1016/j.biopha.2017.12.090 >
2 Noorbala AA et al. “Hydro-alcoholic extract ofCrocus sativusL. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial”.Journal of Ethnopharmacology[Online]. February 28, 2005. Vol. 97, n°2, p. 281‑284. Available at: < https://doi.org/10.1016/j.jep.2004.11.004 >
3 Basiri Moghadam M. et al. “Comparison of the Anxiolytic Effects of Saffron (Crocus sativus. L) and Diazepam Before Herniorrhaphy Surgery: A Double Blind Randomized Clinical Trial”.Zahedan Journal of Research in Medical Sciences[Online]. March 26, 2016. Vol. In Press,. Available at: < https://doi.org/10.17795/zjrms-6248 >
*4 Talaei A. et al. “Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: A randomized, double-blind, placebo-controlled, pilot clinical trial”.Journal of Affective Disorders[Online]. March 15, 2015. Vol. 174, p. 51-56. Available at: < https://doi.org/10.1016/j.jad.2014.11.035 >
*5 Tabeshpour J. et al. “A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativusL.) in mothers suffering from mild-to-moderate postpartum depression”.Phytomedicine[Online]. December 1, 2017. Vol. 36, p. 145-152. Available at: < https://doi.org/10.1016/j.phymed.2017.10.005 >
*6 Mazidi M. et al. “A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression”.Journal of Complementary and Integrative Medicine[Online]. June 1, 2016. Vol. 13, n°2, p. 195‑199. Available at: < https://doi.org/10.1515/jcim-2015-0043 >